Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Explore cartoons & images using related keywords:

antibody

blockade

cancer

cell

checkpoint

death

immune

 immunotherapy inhibition inhibitor membrane oncology pd1 pdl1 programmed protein receptor surface system tcell tlymphocyte tumor

Immune Checkpoint Inhibitors: Interaction Between PD-1 And PD-L1 Blocked By Therapeutic Antibodies Stock Image


Immune checkpoint inhibitors: Interaction between PD-1 and PD-L1 blocked by therapeutic antibodies Stock Photo
Download
Designed by
Title
Immune checkpoint inhibitors: Interaction between PD-1 and PD-L1 blocked by therapeutic antibodies #251599303
Description

Immune checkpoints are regulators of the immune system. Antibodieslight blue and red block the interaction between PD-L1 red molecule on the surface of a cancer cell red and the immune checkpoint PD-1 blue molecule on a T-cell blue, that would lead to the inhibition of T-cell killing tumor cells

Programmed cell death 1 (PD-1, CD279, blue) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, green) protein,
Immune checkpoint inhibitors in cancer treatment
Immune checkpoint inhibitors in cancer treatment
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Programmed cell death 1 (PD-1, CD279, blue) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, red) protein, 3D
Programmed cell death 1 (PD-1, CD279, blue sheets) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, green